Website Changes
11/21/2023
Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology
11/20/2023
Copay Assistance Program is now open!
11/20/2023
GT Medical Technologies, Inc. Presents Use of GammaTile Therapy is Increasing in Time Across Several Brain Tumor Types at the 28th Annual Scientific Meeting and Education Day at the Society of Neuro-Oncology (SNO)
11/01/2023
Air Force investigating potential brain cancer cluster at Cannon AFB
11/01/2023
Ruxolitinib Plus Radiation and Temozolomide is Safe and Feasible for High-Grade Glioma
11/01/2023
VAL-083 Fails to Outperform SOC in Glioblastoma
11/01/2023
Network-targeting combination therapy of leptomeningeal glioblastoma using multiple synthetic lethal strategies: a case report
10/30/2023
GammaTile webinar recording posted to our website!
10/30/2023
FDA OKs Trial for Novel Drug to Treat Glioblastoma and Astrocytoma
10/29/2023
South Florida cancer patient advocates for Promising Pathway Act on Capitol Hill
10/24/2023
10/24/2023
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020
10/24/2023
Chimeric Therapeutics reports positive interim data from CLTX CAR T brain cancer trial
10/24/2023
Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study
10/19/2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
10/18/2023
Our next webinar will be on GammaTile, on Monday Oct 30, 2023
10/18/2023
AI-Augmented Clinical Decision Support in a Patient-Centric Precision Oncology Registry
10/13/2023
Invitation to the Promising Pathway Act Press Conference in Washington, DC, Oct. 26, 2023.
10/13/2023
Optune Overview
09/24/2023
Brain Tumors in United States Military Veterans
09/24/2023
Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials
09/18/2023
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
09/16/2023
FDA expands approval of Temodar to treat additional form of brain cancer
09/14/2023
Deep vein thrombosis as a side effect of cancer: 9 things to know??
09/14/2023
xCures Platform advances progress on the White House Cancer Moonshot mission to end cancer as we know it.
which delivers brain tumor news and additions
to the website via RSS.